0001127602-14-035749.txt : 20141219 0001127602-14-035749.hdr.sgml : 20141219 20141219173530 ACCESSION NUMBER: 0001127602-14-035749 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141218 FILED AS OF DATE: 20141219 DATE AS OF CHANGE: 20141219 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 FORMER COMPANY: FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP DATE OF NAME CHANGE: 19990324 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MAHON PAUL A CENTRAL INDEX KEY: 0001231589 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26301 FILM NUMBER: 141300802 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2014-12-18 0001082554 UNITED THERAPEUTICS Corp UTHR 0001231589 MAHON PAUL A C/O UNITED THERAPEUTICS CORPORATION 1040 SPRING STREET SILVER SPRING MD 20910 1 EVP & General Counsel Common Stock 2014-12-18 4 M 0 4750 30.75 A 39582 D Common Stock 2014-12-18 4 S 0 2289 128.1924 D 37293 D Common Stock 2014-12-18 4 S 0 2151 128.9779 D 35142 D Common Stock 2014-12-18 4 S 0 310 130.0132 D 34832 D Common Stock 2014-12-18 4 M 0 6000 33.14 A 40832 D Common Stock 2014-12-18 4 S 0 6000 131.11 D 34832 D Stock Options 30.75 2014-12-18 4 M 0 4750 0 D 2009-09-14 2017-09-14 Common Stock 4750 0 D Share Tracking Award 33.14 2014-12-18 4 M 0 6000 0 D 2010-03-13 2019-03-13 Common Stock 6000 70750 D This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009. This transaction was executed in multiple trades at prices ranging from $127.73 to $128.63. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $128.74 to $129.48. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $129.81 to $130.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Exercise of a cash-settled share tracking award pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. /s/ John S. Hess, Jr. under Power of Attorney 2014-12-19